uniQure
QURE
#5548
Rank
NZ$2.16 B
Marketcap
NZ$34.76
Share price
-3.08%
Change (1 day)
31.81%
Change (1 year)

uniQure (QURE) - Cash on Hand

Cash on Hand as of September 2025 : NZ$1.19 Billion

According to uniQure's latest financial reports the company has NZ$1.19 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

uniQure - Cash on Hand chart (from 2012 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$0.65 B-33.3%
2023-12-31NZ$0.97 B75.81%
2022-12-31NZ$0.55 B-31.76%
2021-12-31NZ$0.81 B139.91%
2020-12-31NZ$0.33 B-39.49%
2019-12-31NZ$0.56 B60.19%
2018-12-31NZ$0.35 B56.05%
2017-12-31NZ$0.22 B17.32%
2016-12-31NZ$0.19 B-40.93%
2015-12-31NZ$0.32 B292.05%
2014-12-31NZ$82.59 M106.44%
2013-12-31NZ$40 M9362.88%
2012-12-31NZ$0.42 M-76.85%
2011-12-31NZ$1.82 M-94.07%
2010-12-31NZ$30.78 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
NZ$16.30 B 1,260.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
NZ$51.11 M-95.73%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
NZ$0.13 B-88.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
NZ$3.23 B 170.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$18.03 B 1,405.51%๐Ÿ‡ซ๐Ÿ‡ท France
BioMarin Pharmaceutical
BMRN
NZ$2.55 B 112.87%๐Ÿ‡บ๐Ÿ‡ธ USA